Results 261 to 270 of about 4,795,723 (322)

CMV Reactivations During and After Letermovir Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience. [PDF]

Mediterr J Hematol Infect Dis
Olivari E, Pavoni C, Algarotti A, Micò MC, Finazzi MC, Cavallaro G, Rambaldi B, Rizzuto G, Lussana F, Rambaldi A, Grassi A.   +10 more
europepmc   +1 more source

Neighborhood Social Vulnerability and Cardiovascular Risk After Allogeneic Hematopoietic Cell Transplantation. [PDF]

JACC Adv
Bhandari R, Ogiamien O, Chen S, Al Malki M, Artz AS, Bosworth A, Echevarria M, Rhee JW, Wong FL, Armenian SH.   +9 more
europepmc   +1 more source

End points for sickle cell disease clinical trials: Renal and cardiopulmonary, cure, and low-resource settings [PDF]

, 2019
al., et, Farrell, Ann T., Shenoy, Shalini   +2 more
core   +1 more source

The impact of donor and recipient age on post-transplantation clonality in murine hematopoiesis. [PDF]

Stem Cells
Thielecke L, Nattamai K, Hassan A, Glauche I, Geiger H, Cornils K.   +5 more
europepmc   +1 more source

Next generation targeted non-genotoxic conditioning for hematopoietic stem cell and hematopoietic stem cell-based gene therapy. [PDF]

Front Immunol
Okalova J, Spencer TH, Chandrakasan S.
europepmc   +1 more source

Donor age as an independent predictor of inferior outcomes after haploidentical hematopoietic cell transplantation in acute myeloid leukemia. Study conducted on behalf of GETH-TC. [PDF]

Front Immunol
Munárriz D, Pérez-López E, Martín Rodríguez C, Luque M, Esquirol A, Calvo CM, Aparicio C, Peña-Muñóz F, Heras Fernando I, Oiartzabal Ormtegi I, Sáez Marín AJ, Fernández-Luis S, Domínguez-García JJ, Villar Fernández S, López-Lorenzo JL, Acosta Fleitas C, González-Rodriguez AP, García L, Torrado T, Filaferro S, Balsalobre P, Pascual Cascon MJ, Rovira M, Queralt Salas M.   +23 more
europepmc   +1 more source

Renal homotransplantation in man: followup of 189 cases [PDF]

, 1970
Gray, S, Matineau, GL, Starzl, TE, Takagi, H   +3 more
core  

Mitochondrial DAMPs as a critical driver in the development of acute graft versus host disease and emerging mitochondria targeted therapeutic strategies. [PDF]

Front Immunol
Raguraman V, Prabhu YD, Velmurugan GV, Hildebrandt GC, Palaniyandi S.   +4 more
europepmc   +1 more source

Efficacy and safety of Busulfan-Fludarabine versus Busulfan-Cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: a meta-analysis of randomized controlled trials and observational studies. [PDF]

Ther Adv Hematol
Ali A, Ali MA, Afridi A, Ali H, Ul Haq U, Osama M, Umar Afridi M, Azeem T, Masaud MA, Khattak F, Safeer F, Khan A, Sufyan Darwesh M, Ehsan N, Zia W, Riffat G, Moeez A, Kamil KA.   +17 more
europepmc   +1 more source